Company Information

CIN
Status
Date of Incorporation
02 August 2001
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
28 September 2023
Paid Up Capital
12,800,000
Authorised Capital
15,000,000

Directors

Rajasekhar Reddy Tummuru
Rajasekhar Reddy Tummuru
Director/Designated Partner
about 2 years ago
Veera Venkata Satyanarayana Reddy Dodda
Veera Venkata Satyanarayana Reddy Dodda
Director/Designated Partner
about 2 years ago
Satyanarayana Reddy Bhimireddy
Satyanarayana Reddy Bhimireddy
Director/Designated Partner
over 2 years ago
Stefano Vanossi .
Stefano Vanossi .
Director/Designated Partner
over 3 years ago
Manuel Ignacio Barro
Manuel Ignacio Barro
Director/Designated Partner
about 6 years ago

Past Directors

Maria Sandra Martin Moran
Maria Sandra Martin Moran
Director
over 10 years ago
Gustavo Daniel Lorenzo Pelizzari
Gustavo Daniel Lorenzo Pelizzari
Director
over 19 years ago

Patents

Process For Preparation Of Vilazodone And Its Novel Intermediates

The invention relates to process for preparation of Vilazodone and novel intermediates for synthesis of Vilazodone.

Process For Preparation Of Vilazodone, Novel Intermediates Thereof And Novel Crystalline Form Thereof

The invention relates to process for preparation of Vilazodone and novel intermediates for synthesis of Vilazodone. The invention also relates to novel crystalline form of Vilazodone hydrochloride and process for preparation thereof.

Process For Preparation Of Oxazolidinone Derivatives

A process for preparation of oxazolidinone derivatives, more particularly, a combined process for preparation of Linezolid and Rivaroxaban and novel intermediates for preparation of Oxazolidinone derivatives.

Improved Process For The Synthesis Of Amorolfine And Its Hydrochloride Salt

The invention discloses an improved process for the preparation of Amorolfine Base of Formula-I which is further converted into the Active Pharmaceutical Ingredient (API) Amorolfine Hydrochloride of Formula-Ia. The Amorolfine Hydrochloride obtained by the process has high HPLC purity and reduced impurities like Fenp...
An improved process for preparation of Cis-4-[4-[4-[4-[[2-(2 4-Dichlorophenyl)-2-(1H-1 2 4-triazol-1-ylmethyl)-1 3-dioxolan-4-yl]-methoxy]phenyl]-1-piperaz-inyl]phenyl]-2 4-dihydro-2-(1-methyl-propyl)-3H-l 2 4-triazol-3-one (itraconazole) represented by compound of formula-A. The process comprises condens...

Process For Preparation Of Oxazolidinone Derivatives

A process for preparation of oxazolidinone derivatives such as Linezolid and Rivaroxaban using (S)-Epichlorohydrin.

Process For Preparing Crystalline Linezolid Form Iii

Novel process for preparing crystalline Linezolid Form III is disclosed.

Rosuvastatin Amine And Indanamine Salts And Process For Preparation Thereof

ROSUVASTATIN AMINE AND INDANAMINE SALTS AND PROCESS FOR PREPARATION THEREOF A rosuvastatin amine or indanamine salt of the formula-1 which can be used for preparation of pharmaceutically acceptable salts of rosuvastatin like rosuvastatin calcium or rosuvastatin magnesium. The obtained rosuvastatin amine or indanami...

Registered Trademarks

Device Of Nosch Nosch Labs

[Class : 5] Pharmaceutical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides, Herbicides;

Nosch (Label) Nosch Labs

[Class : 5] Pharmaceutical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides, Herbicides

Nosch Nosch Labs

[Class : 5] Pharmaceutical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides, Herbicides

Charges

85 Crore
15 April 2002
Centurian Bank Ltd 94
2 Lak
08 April 2002
Axis Bank Limited
85 Crore
21 June 2004
Uti Bank
45 Lak
08 April 2002
Uti Bank Limited
60 Lak
08 April 2002
Uti Bank Limited
0
21 June 2004
Uti Bank
0
15 April 2002
Centurian Bank Ltd 94
0
08 April 2002
Axis Bank Limited
0
08 April 2002
Uti Bank Limited
0
21 June 2004
Uti Bank
0
15 April 2002
Centurian Bank Ltd 94
0
08 April 2002
Axis Bank Limited
0
08 April 2002
Uti Bank Limited
0
21 June 2004
Uti Bank
0
15 April 2002
Centurian Bank Ltd 94
0
08 April 2002
Axis Bank Limited
0

Documents

Form ADT-1-05092020_signed marked as defective by Registrar on 03-08-2021
Optional Attachment-(1)-04092020 marked as defective by Registrar on 03-08-2021
Copy of resolution passed by the company-04092020 marked as defective by Registrar on 03-08-2021
Copy of written consent given by auditor-04092020 marked as defective by Registrar on 03-08-2021
Form DPT-3-26122020_signed
Form AOC-4(XBRL)-16122020_signed
Form MGT-7-17112020_signed
Optional Attachment-(1)-15112020
List of share holders, debenture holders;-15112020
Copy of MGT-8-15112020
Form MGT-7-07092020_signed
Form ADT-1-05092020_signed
Copy of resolution passed by the company-04092020
Optional Attachment-(1)-04092020
List of share holders, debenture holders;-04092020
Copy of MGT-8-04092020
Copy of written consent given by auditor-04092020
Form MSME FORM I-25062020
Form MSME FORM I-25062020_signed
Form DPT-3-11062020-signed
Form ADT-1-26022020_signed
Copy of resolution passed by the company-26022020
Copy of written consent given by auditor-26022020
Copy of the intimation sent by company-26022020
Optional Attachment-(1)-26022020
Form AOC-4(XBRL)-30112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28112019
Form MGT-14-17112019_signed
Optional Attachment-(2)-05112019
Optional Attachment-(3)-05112019